So Totally Random
Clinical Study
Renasys Pump Up
PICO de Gallo
SHARK Attack
100

Years PICO has been on the market

10 years

100

Use of PICO sNPWT to reduce wound area, depth and volume compared with traditional NPWT in patients with VLUs and DFUs 

Kirsner

100

Our brand manager for Renasys 

Brian Conroy

100

Our corporate contact for PICO marketing

Melissa Ramirez

100
The 5 states the SW Device Sharks District covers

California, Arizona, Nevada, New Mexico, Texas

200

Our contact for NPWT pricing and contracting

Sarah Mattler
200

It is increasingly apparent that there may not be one single optimal level of pressure but a therapeutic range.

Recent evidence suggests that, clinical outcomes are favorable irrespective of which treatment variables are applied.

All Things Being Equal

200

Battery life for Renasys Touch and Go

20 and 16 hours

200

The amount of exudate PICO hold in 7 days

300ml

200

Our Care Continuum Director

Kevin Belanger 

300

Largest organ of the body

The Skin

300

Use of PICO sNPWT after C-Section helped reduce Surgical site infections SSIs compared to standard dressings with similar costs for pre-pregnancy BMI greater than 30kg/m

Hyldig

300

Benefits of Softport Technology

May reduce the need to bridge and may reduce device acquired pressure ulcers. 
300

Deepest wound that PICO can treat

4.5cm

300

The SW Device teams Rookie of the year 2021 and SEC winner

Danny Evans and Stefanie Koenig

400

PICO reimbursement $ in a Physician office

About 390 ($391.74 - $396.93)

400

Prophylactic use of PICO sNPWT reduced wound breakdown resulting in fewer implant losses with estimated cost savings compared with standard dressings in prepectorial breast reconstruction.

Irwin

86% relative reduction in wound breakdown

0 implants lost

$626 estimated cost savings per pt.

196 pts in the study

400

Pressure setting range of Renasys Touch and Renasys Go

Touch = -25mmhg - -200mmhg

Go = -40mmgh - -200mmgh

400

PICO Contraindications

The use of PICO™ 7 is contraindicated in the presence of: 

• Patients with malignancy in the wound bed or margins of the wound (except in palliative care to enhance quality of life). 

• Previously confirmed and untreated osteomyelitis. 

• Non-enteric and unexplored fistulas. 

• Necrotic tissue with eschar present. 

• Exposed arteries, veins, nerves or organs.  

400

The 3 culture pillars of Smith+Nephew

Care

Courage

Collaboration

500

The 3 winning plays for Device

PICO 3X5

Renasys Acute

Renasys Post-Acute

500

Advanced Wound Therapies in the Management of Severe Military Lower Limb Trauma: A New Perspective

Tx of injuries resulting from land mine explosions using a holistic approach that includes gauze-based NPWT.

Lt. Col Jeffery

Clinical benefit involving wound bed prep and infection control strategies. 

Gauze is versatile and capable of being applied in a wide variety of wounds . Gauze is conformable and easy to apply. Helps with comfort and reduces pain.

500

The antimicrobial property in our Gauze

Polyhexamethylene Biguanide (PHMB) - Antiseptic with antiviral and antibacterial properties.

500

PICOs 2 new indications for use

1. PICO SSI indication. Superficial and deep incisional surgical site infections for high risk patients in Class 1 and 2 wounds. Post-perative Seroma. Dehisence.

2. VLU - PICO7 & 14 with graduated compression therapy.

NEW IFU

500

3 T's of Challenger

Teach, Tailor, Take Control

M
e
n
u